(818) 431-5208

info@mahealthcareadvisors.com

REFERRAL PROGRAM

BUYER REGISTRATION
  • WHO WE ARE
  • SERVICES
    • Sell Your Company
    • M&A Consultation
    • Expert Valuations
    • Broker-Dealer
  • TRANSACTIONS
  • INSIGHTS
    • The Selling Process
    • The M&A Market
    • M&A Insights Podcast
  • PRESS
  • CONTACT US

Press

We Manage the Sale Process, So You Can Manage Your Business


The Selling Process, Video

How Long Does the Sale Process Take?

As markets become more saturated and competition intensifies, companies seek M&A as a means to consolidate market share, expand their

June 20, 2023
Read More
Press

Featured Contribution: Optum offer for Amedisys trumps Option Care Health deal, experts say

“The reason that the Optum deal is more attractive, other than it being a better price, is because Optum is

June 8, 2023
Read More
M&A Healthcare Advisors (MAHA) Successfully Represents In-Home Physicians Practice, Medical House Calls with Compassion in Their Sale
Press

M&A Healthcare Advisors (MAHA) Successfully Represents In-Home Physicians Practice, Medical House Calls with Compassion, in Their Sale

M&A Healthcare Advisors (MAHA) Successfully Represents In-Home Physicians Practice, Medical House Calls with Compassion, in Their Sale Los Angeles, CA

May 19, 2023
Read More
Announcement that Mark Thomas and Mike Abud will be attending the CAHSAH conference
Events

Join Us at the California Association of Health Services at Home Annual Conference and Expo

Next week, our team will be attending the California Association of Health Services at Home Annual Conference and Expo in

May 18, 2023
Read More
What the Option Care Health-Amedisys deal says about home care? M&A Healthcare Advisors Weighs-In
Press

What the Option Care Health-Amedisys deal says about home care?

Option Care Health’s plan to buy home care giant Amedisys for $3.6 billion continues a trend of providers, payers and

May 10, 2023
Read More
Press

What’s ahead for Option Care Health? M&A Healthcare Advisors Weighs-In

The recent disclosure of the merger between home health and hospice provider Amedisys and infusion services provider Option Care Health

May 9, 2023
Read More
Video: 3 Key Takeaways from the Healthcare Transactions Conference
The M&A Market, Video

Video: 3 Key Takeaways from the Healthcare Transactions Conference

Video: 3 Key Takeaways from the Healthcare Transactions Conference In this video, Mark Thomas, Co-Founder and Director of Operations at

May 4, 2023
Read More
Press

M&A Healthcare Advisor’s Latest Transaction Featured in Hospice News

LHC Group has acquired Delaware-based Summit Home Care for an undisclosed sum, signaling that the company will remain active on

April 25, 2023
Read More
Press

M&A Healthcare Advisors Featured in Becker’s Coverage of LHC’s Acquisition of Summit Home Health

M&A Healthcare Advisor’s latest transaction was featured in Becker’s Healthcare publication. In the article, they detail UnitedHealth Group’s recently acquired

April 25, 2023
Read More
Join Us At Autism Investor Summit & Health Law Transactions Conference
Events

Join Us at Autism Investor Summit & Health Law Transactions Conference

Next week, our team will be attending the Autism Investors Summit in West Hollywood, CA and the Health Law Transaction

April 13, 2023
Read More
Load More
(818) 431-5208 | info@mahealthcareadvisors.com | M&A Healthcare Advisors, 4500 Park Granada Blvd, Suite 202, Calabasas, CA 91302
About Transactions Insights Press Contact Us Privacy Policy
Securities are offered through Finalis Securities LLC , Member FINRA / SIPC . M&A Healthcare Advisors is not a registered broker-dealer, and M&A Healthcare Advisors and Finalis Securities LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
www.mahealthcareadvisors.com (the “M&A Healthcare Advisors Website”) is a website operated by M&A Healthcare Advisors. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy and is subject to change without notice.
Finalis Privacy Policy | Business Continuity Plan | FINRA BrokerCheck | SIPC | Finalis Form CRS
Copyright © 2026 M&A Healthcare Advisors. All rights reserved.

Market Research

The first step in any valuation is to explore what drives value within your specific market segment. In the healthcare sector, understanding industry trends and identifying key market drivers is essential to understanding what makes your business unique.

  • Industry Trends: The healthcare landscape is constantly evolving. Factors such as regulatory changes, technological advancements, reimbursement risk, skilled caregiver supply, and shifts in patient demographics can significantly impact your business’s value. Staying ahead of these trends and adapting your operations accordingly can make your company more attractive to potential buyers in the market.
  • Key Market Drivers: Patient outcomes, cost-efficiency, and specialized services are often critical value drivers in the eyes of a potential acquirer. For example, a company with a track record of delivering better patient outcomes or offering services that are currently in high demand can be factors which elevate your perceived valuation.
  • Identifying Competition and Market Position: Benchmarking your business against competitors or other operator profiles can provide a clearer picture of your market position. This involves analyzing competitor strengths, weaknesses, and growth strategies to highlight your company’s competitive advantage.

Transaction Comparatives

Once we have a solid understanding of your market, we move on to examining recent transactions in the healthcare sector to identify valuation benchmarks.

  • Assessing Comparable Transactions: By analyzing similar deals, we identify comparable businesses that have recently gone through an M&A transaction. This helps us understand the market’s value expectations for companies that operate with a similar profile to your business. While every business is unique, one of the most effective ways to estimate the value of your business is through benchmarking your company with similar companies who have sold in the open market.  With our extensive experience in healthcare M&A, we have transactional comparative data t relative to your business.
  • Market Multiples: One of the key metrics utilized in M&A is the Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiple. EBITDA multiples can offer insight into the value of your business based on its profitability. For example, if comparable companies were recently acquired between 5x – 7x EBITDA, this will be one of the reference points we will utilize in determining our opinion of value.
  • Case Study: We’ll also look at recent acquisitions of companies operating in the same segment and size as you. By examining common valuation drivers, financial metrics, and EBITDA multiples, we can draw parallels to your business and refine our opinion of value further.

Financial Analysis

Once we have market and transactional insights, it’s time to perform a detailed analysis of your business’s financial health and growth prospects.

  • Reviewing Financial Health: We analyze key metrics like revenue growth, profit margins, and operating efficiency to assess how well your business is and has been performing. Consistent (or growing) financials can not only boost your valuation in the market but also demonstrate to buyers that your company is a stable and profitable investment.
  • Impact of Assets and Liabilities: Your business’s assets—such as licenses, medical equipment, inventory, entitled real estate, and proprietary technology— may play a role in determining its value. In certain segments, like behavioral health—substance use disorder clinics, it is vital that out-of-network groups have a standardized marketing system for patient acquisition. Conversely, liabilities like outstanding penalties, reimbursement claw backs, charting/clinical data deficiencies, or restrictive contractual obligations can impact the final valuation.  For example, in hospice it is important to have a program to reduce your cap liability and ensure that all patient charts are completed per the current regulatory standards.
  • Projections and Future Cash Flows: In M&A, it’s not just about your current financials; it’s about where your business is headed. We develop grounded financial projections based on current market conditions, historical performance, and growth potential to demonstrate your company’s future cash flow potential.

Conclusion & Findings

After conducting market research and a thorough analysis of your businesses operational, clinical, and financial performance, we compile our findings to deliver a comprehensive valuation reports.

  • Presenting a Valuation Opinion: We summarize all of the data gathered to provide you with a clear opinion of your business’s value. This valuation is supported by concrete data and expert analysis, ensuring transparency and credibility.
  • Next Steps: Once you have a solid understanding of your company’s value, you’ll be in a strong position to pursue your M&A goals. Whether you’re looking to sell now or later, knowing your valuation allows you to plan your next moves more strategically.

Understanding the process of valuation a healthcare company in today’s market is essential if you’re considering any type of capital event in the near future. By exploring key market drivers, examining recent transactions, conducting a thorough financial analysis, and delivering a well-supported valuation, you can approach any M&A related event with confidence.

Going through the steps of conducting a formal valuation not only helps you gain a clear picture of your company’s worth but also provides you with the opportunity to reach maximum value when entering the market to sell or raise capital. Having a third-party, data-driven analysis can equip you with the information and knowledge to successfully navigate a sale process. At M&A Healthcare Advisors, our goal is to guide you through every step of the way, so you can focus on what matters most—growing and transitioning your business successfully.